Sanofi Consumer Healthcare India Limited has announced its financial results for the third quarter and nine months ended September 30, 2026. The company reported a revenue of ₹2,631 million and a net profit of ₹1,027 million for the quarter. This signifies profitable growth driven by domestic sales and a strategic focus on key brands.
Sanofi Consumer Healthcare India Limited Reports Strong Q3 Performance
Sanofi Consumer Healthcare India Limited has declared its unaudited financial results for the third quarter and nine months that concluded on September 30, 2026. The company demonstrated significant profitable growth across its business segments, highlighted by a revenue of ₹2,631 million for the quarter, marking a 12% year-on-year increase.
Key Financial Highlights
For the quarter ended September 30, 2026:
- Revenue stood at ₹2,631 million, a growth of 12% year-on-year.
- Domestic Sales experienced a robust growth of 19%.
- Earnings Per Share (EPS) grew by 22%, reaching INR 5.95, driven by increased revenue.
- Profit Before Tax (PBT) saw a substantial increase of 22%.
The results for the nine months ended September 30, 2026, also showed strong momentum:
- Revenue from Operations reached ₹7,280 million, a 16% growth year-on-year.
- Domestic Sales grew by 15%, aided by product relaunches.
- Export Sales increased by 19%.
- Profit Before Tax was up by 24%.
Strategic Commentary
Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, commented on the performance, stating, “Our Q3 performance reflects the disciplined execution of our strategy and the strength of our portfolio. We delivered healthy growth, driven by volume expansion and market share gains across key brands. Our investments in brand building and expanding our distribution footprint and Healthcare Professional reach are enabling us to serve more consumers.”
Unaudited Financial Results Summary
The unaudited financial results for the quarter ended September 30, 2026, show a Profit Before Tax of ₹1,027 million, with a Tax Expense of ₹266 million, leading to a Net Profit of ₹766 million. For the nine months ended September 30, 2026, the Profit Before Tax was ₹2,853 million, Tax Expense was ₹741 million, and Net Profit was ₹2,132 million.
Source: BSE
